Chris Andrews (singer) then a string of hits for Sandie Shaw. They included "Girl Don't Come" (No. 3, 1964/65), "I'll Stop at Nothing" (No. 4, 1965), "Message Understood" (No. 6, 1965) and "Long Live Love" (No. 1, 1965). The latter remained a chart topper in the UK Singles Chart for three weeks. "Girl Don't Come" was covered by Cher on her debut album, "All I Really Want to Do". Also in 1965, Andrews as a solo artist, got to No. 3 in the same listings with "Yesterday Man", which peaked in Germany at No. 1 for four weeks; followed up with a No.
YM Biosciences the FDA for Phase II trials in both Non-Small Cell Lung cancer and Brain Metastases from NSCLC. In Canada, in June 2007, the company received clearance from Health Canada to begin a Phase II trial of nimotuzumab in colorectal cancer patients who had not responded to previous treatments. YM Biosciences YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. YM